Deloitte January 8, 2019
My Take
As we head into 2019, I expect that tackling pricing, spending, and costs for prescription drugs will become an even more important issue for the White House and the 116th Congress. About 80 percent of Americans rank drug pricing as the top priority for lawmakers—above reducing the federal budget deficit or increasing the investment in infrastructure—according to a recent survey published in Politico.1
What actions might we see in 2019? It has been eight months since the administration released its Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs (see the June 19, 2018 My Take). Before we get into what might happen in the year ahead, let’s first take a look at the policies that are already...